<DOC>
	<DOCNO>NCT00262470</DOCNO>
	<brief_summary>This trial design study effect various mechanistically unique medication control excessive increase heart rate stand improve symptom orthostatic intolerance patient disorder .</brief_summary>
	<brief_title>Treatment Orthostatic Intolerance</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Orthostatic Intolerance</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<mesh_term>Midodrine</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<mesh_term>Mecamylamine</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<mesh_term>Isosorbide</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<mesh_term>Entacapone</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<mesh_term>Isosorbide-5-mononitrate</mesh_term>
	<mesh_term>Isosorbide Dinitrate</mesh_term>
	<criteria>Chronic symptom ( &gt; 6 month ) stand upright Obvious cause hypovolemia drug could worsen tachycardia Chronic severe medical condition cancer ischemic heart disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>tachycardia</keyword>
	<keyword>sinus tachycardia</keyword>
	<keyword>postural tachycardia syndrome ( POTS )</keyword>
</DOC>